XML 207 R109.htm IDEA: XBRL DOCUMENT v3.25.4
Income tax expense/(benefit) - Schedule of Numerical Reconciliation of Prima Facie Tax Payable to Income Tax Expense/(Benefit) (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Reconciliation of accounting profit multiplied by applicable tax rates [abstract]      
(Loss)/profit before income tax $ (5,266) $ 37,915 $ 2,594
Applicable tax rate 30.00% 30.00% 30.00%
Prima-facie tax at a rate of 30.0% (2023: 30.0%, 2022: 30.0% ) $ (1,580) $ 11,375 $ 778
Tax effect of amounts which are not deductible (taxable) in calculating taxable income:      
Net R&D tax incentive credit (1,425) (13,818) (4,889)
Remeasurement of provisions 589 4,910 9,183
Share-based payments expense & Employee Share Trust payments (8,442) (1,301) (5,372)
Sundry items 81 371 375
Foreign exchange translation gains 360 0 678
Total (10,417) 1,537 753
Current year tax losses not recognized 17,765 40,522 23,197
Difference in overseas tax rates (5,489) (37,829) (25,564)
Income tax expense/(benefit) $ 1,859 $ 4,230 $ (1,614)